Elbit Medical Technologies Ltd
ELBDF
$0.05
-$0.01-16.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 104.65% | 34.43% | -316.52% | -276.22% | -248.15% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -107.68% | -35.85% | 377.04% | 320.37% | 282.65% |
| Change in Net Operating Assets | -147.37% | 40.00% | 66.18% | -25.00% | -122.62% |
| Cash from Operations | 8.14% | 12.87% | 16.86% | 4.40% | -12.17% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -91.88% | -84.13% | 376.47% | 213.41% | 203.17% |
| Cash from Investing | -91.88% | -84.13% | 376.47% | 213.41% | 203.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 65.71% | 64.91% | 64.56% | 85.52% | 90.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -127.96% | -228.92% | 39.87% | 123.70% | 142.91% |